Bio-Works Technologies AB Total Liabilities

Latest as of December 2025: Skr21.55 Million SEK ≈ $2.32 Million USD

Bio-Works Technologies AB total liabilities. Based on the latest financial reports, Bio-Works Technologies AB (BIOWKS) has total liabilities worth Skr21.55 Million SEK (≈ $2.32 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Bio-Works Technologies AB defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Bio-Works Technologies AB (2015–2025)

Total liabilities of Bio-Works Technologies AB from 2015 to 2025. This chart illustrates how Bio-Works Technologies AB's total liabilities have evolved over time, based on quarterly financial data.

Bio-Works Technologies AB Competitors by Total Liabilities

The table below lists competitors of Bio-Works Technologies AB ranked by their total liabilities.

Company Country Total Liabilities
Communication & System Solution Public Company Limited
BK:CSS
Thailand ฿1.22 Billion
Hastings Technology Metals Ltd
AU:HAS
Australia AU$137.26 Million
Li Kang Biomedical Co Ltd
TWO:6242
Taiwan NT$212.01 Million
Shaftesbury Capital PLC
LSE:SHC
UK GBX1.04 Billion
Cipherlab Co Ltd
TWO:6160
Taiwan NT$543.98 Million
EVZ Ltd
AU:EVZ
Australia AU$36.89 Million
Tinka Resources Limited
V:TK
Canada CA$604.93K
Eurospan Holdings Bhd
KLSE:7094
Malaysia RM31.91 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Bio-Works Technologies AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Bio-Works Technologies AB assets under control.

Liquidity & Leverage Metrics

Bio-Works Technologies AB Total Liabilities Ratios Explained

Bio-Works Technologies AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.44 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bio-Works Technologies AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bio-Works Technologies AB (2015–2025)

The table below shows the annual total liabilities of Bio-Works Technologies AB from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 Skr21.55 Million
≈ $2.32 Million
+172.34%
2024-12-31 Skr7.91 Million
≈ $851.57K
-56.33%
2023-12-31 Skr18.12 Million
≈ $1.95 Million
-24.25%
2022-12-31 Skr23.92 Million
≈ $2.57 Million
+93.65%
2021-12-31 Skr12.35 Million
≈ $1.33 Million
+53.57%
2020-12-31 Skr8.04 Million
≈ $865.66K
+36.48%
2019-12-31 Skr5.89 Million
≈ $634.29K
+2.26%
2018-12-31 Skr5.76 Million
≈ $620.30K
-3.76%
2017-12-31 Skr5.99 Million
≈ $644.51K
+35.01%
2016-12-31 Skr4.44 Million
≈ $477.38K
+92.79%
2015-12-31 Skr2.30 Million
≈ $247.62K
--

About Bio-Works Technologies AB

ST:BIOWKS Sweden Medical Instruments & Supplies
Market Cap
$32.93 Million
Skr306.03 Million SEK
Market Cap Rank
#23234 Global
#437 in Sweden
Share Price
Skr3.06
Change (1 day)
-7.27%
52-Week Range
Skr2.21 - Skr4.68
All Time High
Skr28.60
About

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chr… Read more